These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 29062976)
41. The IGF-1R/AKT pathway determines cell fate in response to p53. Duan L; Maki CG Transl Cancer Res; 2016 Dec; 5(6):664-675. PubMed ID: 28966916 [TBL] [Abstract][Full Text] [Related]
42. The role of DNA damage responses in p53 biology. Speidel D Arch Toxicol; 2015 Apr; 89(4):501-17. PubMed ID: 25618545 [TBL] [Abstract][Full Text] [Related]
43. Dynamical analysis of cellular ageing by modeling of gene regulatory network based attractor landscape. Chong KH; Zhang X; Zheng J PLoS One; 2018; 13(6):e0197838. PubMed ID: 29856751 [TBL] [Abstract][Full Text] [Related]
44. N-methyl-N'-nitro-N-nitrosoguanidine-induced senescence-like growth arrest in colon cancer cells is associated with loss of adenomatous polyposis coli protein, microtubule organization, and telomeric DNA. Jaiswal AS; Multani AS; Pathak S; Narayan S Mol Cancer; 2004 Jan; 3():3. PubMed ID: 14728717 [TBL] [Abstract][Full Text] [Related]
45. Regulation of Tip60-dependent p53 acetylation in cell fate decision. Wang P; Bao H; Zhang XP; Liu F; Wang W FEBS Lett; 2019 Jan; 593(1):13-22. PubMed ID: 30414319 [TBL] [Abstract][Full Text] [Related]
46. p19(Arf) is required for the cellular response to chronic DNA damage. Bieging-Rolett KT; Johnson TM; Brady CA; Beaudry VG; Pathak N; Han S; Attardi LD Oncogene; 2016 Aug; 35(33):4414-21. PubMed ID: 26725325 [TBL] [Abstract][Full Text] [Related]
47. Cell fate regulation governed by p53: Friends or reversible foes in cancer therapy. Song B; Yang P; Zhang S Cancer Commun (Lond); 2024 Mar; 44(3):297-360. PubMed ID: 38311377 [TBL] [Abstract][Full Text] [Related]
48. Dual roles of SIRT1 in the BAX switch through the P53 module: A mathematical modeling study. Liu N; Yang H; Yang L Comput Struct Biotechnol J; 2021; 19():5578-5588. PubMed ID: 34849192 [TBL] [Abstract][Full Text] [Related]
49. Mathematical Modelling of p53 Signalling during DNA Damage Response: A Survey. Eliaš J; Macnamara CK Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638930 [TBL] [Abstract][Full Text] [Related]
50. Apoptotic mechanism activated by blue light and cisplatinum in cutaneous squamous cell carcinoma cells. Tartaglione MF; Eléxpuru Zabaleta M; Lazzarini R; Piva F; Busilacchi EM; Poloni A; Ledda C; Rapisarda V; Santarelli L; Bracci M Int J Mol Med; 2021 Apr; 47(4):. PubMed ID: 33576463 [TBL] [Abstract][Full Text] [Related]
51. Cellular Responses to Platinum-Based Anticancer Drugs and UVC: Role of p53 and Implications for Cancer Therapy. Murray D; Mirzayans R Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32796711 [TBL] [Abstract][Full Text] [Related]
52. A systematic approach to decipher crosstalk in the p53 signaling pathway using single cell dynamics. Konrath F; Mittermeier A; Cristiano E; Wolf J; Loewer A PLoS Comput Biol; 2020 Jun; 16(6):e1007901. PubMed ID: 32589666 [TBL] [Abstract][Full Text] [Related]
53. Frequency switching between oscillatory homeostats and the regulation of p53. Ruoff P; Nishiyama N PLoS One; 2020; 15(5):e0227786. PubMed ID: 32433703 [TBL] [Abstract][Full Text] [Related]
54. Sliding mode controller-observer pair for p53 pathway. Rizwan Azam M; Utkin VI; Arshad Uppal A; Bhatti AI IET Syst Biol; 2019 Aug; 13(4):204-211. PubMed ID: 31318338 [TBL] [Abstract][Full Text] [Related]